Join the Conversation!

So I think the development continues, but we’re hoping that pacritinib still has a role maybe in a particular set of patients.

~Dr. Naval Daver, MD Anderson, on the status of the pacritinib trial

Featured Programs

PV Reporter David Wallace: ASH15 Highlights for MPN Patients

On location at the 2015 American Society of Hematology (ASH), Carol Preston speaks with founder, David Wallace about his website, defining PV as a cancer and the positive results coming out of combination therapy trials.


An Endurance Athlete Shares Her Story of Living Well With PV

Angie Feser is an endurance athlete who was diagnosed with essential thrombocythemia (ET) and later polycythemia vera (PV) in the last year. She shares her story about seeking expert care for her PV, treatment with phlebotomy, and how she stays active and manages the mental challenge of dealing with a cancer diagnosis.


MPN Updates From ASH With Dr. Naval Daver

At the 2015 American Society of Hematology (ASH) annual meeting, Dr. Naval Daver of MD Anderson Cancer Center speaks candidly regarding the future of research and treatment for MPN patients.


Featured Blog
A Robust Conversation About a Thorny Topic

By C.J. Chris

Page last updated on July 29, 2016